Cigna Corporation (NYSE:CI) shares traded lower over the last trading session, losing -0.08% on 05/26/21. The shares fell to a low of $255.53 before closing at $259.39. Intraday shares traded counted 1.24 million, which was 23.63% higher than its 30-day average trading volume of 1.63M. CI’s previous close was $259.60 while the outstanding shares total 348.65M. The firm has a beta of 0.90, a 12-month trailing P/E ratio of 11.15, and a growth ratio of 0.88. The stock’s Relative Strength Index (RSI) is 53.94, with weekly volatility at 1.57% and ATR at 4.71. The CI stock’s 52-week price range has touched low of $158.84 and a $272.81 high.
Investors have identified the Healthcare Plans company Cigna Corporation as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $88.47 billion, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
Having a look at the company’s valuation, the company is expected to record 23.24 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on CI sounds very interesting.
Is the stock of CI attractive?
In related news, President & CEO, Cordani David sold 62,123 shares of the company’s stock in a transaction that recorded on May 07. The sale was performed at an average price of 260.83, for a total value of 16,203,311. As the sale deal closes, the President & CEO, Cordani David now sold 42,772 shares of the company’s stock, valued at 10,939,766. Also, President & CEO, Cordani David sold 6,207 shares of the company’s stock in a deal that was recorded on Apr 21. The shares were price at an average price of 255.39 per share, with a total market value of 1,585,195. Following this completion of acquisition, the EVP, General Counsel, Jones Nicole S now holds 19,375 shares of the company’s stock, valued at 4,873,001. In the last 6 months, insiders have changed their ownership in shares of company stock by 0.20%.
21 out of 26 analysts covering the stock have rated it a Buy, while 4 have maintained a Hold recommendation on Cigna Corporation. 0 analysts has assigned a Sell rating on the CI stock. The 12-month mean consensus price target for the company’s shares has been set at $291.42.